Cargando…
Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog
OBJECTIVE: Describe the clinical course and management of a dog that underwent hematopoietic stem cell transplantation (HSCT) for treatment of B‐cell lymphoma and developed acquired circulating factor V (FV) inhibitors. CASE SUMMARY: An 8‐year‐old male castrated Briard dog diagnosed with lymphoma (I...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517841/ https://www.ncbi.nlm.nih.gov/pubmed/32686109 http://dx.doi.org/10.1111/jvim.15845 |